Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

153
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

103
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial

Pages

  523-532

Abstract

 Objective: Golnar product is a poly herbal formulation advised by Persian medicine to control heavy menstrual bleeding (HMB). This study was conducted to compare the efficacy of this product with placebo in patients with HMB. Materials and Methods: In this double-blind randomized clinical trial, 100 women with HMB were randomly assigned into two groups. The patients in the Golnar group (n=50) took Golnar capsules 500 mg three times a day for the first 7 days of menstrual cycle for three cycles. The placebo group (n=50), took placebo capsules in the same manner. The duration and volume of bleeding (using Pictorial Blood Loss Assessment Chart: PBAC), quality of life (using Menorrhagia Questionnaire: MQ), and hemoglobin level (Hb) were measured 3 months after initiation of the intervention. Results: Eighty-two patients (43 in the Golnar and 39 in the placebo groups) completed the 3-month intervention period. In the Golnar group, PBAC score decreased from 201. 62 (144. 11) to 109. 44 (69. 57) (p<0. 001) and MQ score improved significantly from 0. 58 (0. 27) to 0. 39 (0. 31) (p<0. 001), while changes in placebo group were not significant. Hb increased in the Golnar group from 12. 78± 0. 98 to 12. 97± 0. 95 mg/dl (p=0. 048) and decreased in the placebo group from 12. 94± 1. 08 to 12. 44± 1. 01mg/dl (p<0. 001). No significant adverse effects were found in the Golnar group. Conclusion: The Golnar product can be considered an effective intervention for patients with HMB. Assessment of side-effects is suggested to be performed in a larger sample. In addition, a comparison between the Golnar product and nonsteroidal anti-inflammatory drugs could be valuable.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    YOUSEFI, FATEMEH, KASHANIAN, MARYAM, Nazem, Ismail, BIOOS, SOODABEH, SADEGHPOUR, OMID, ALIASL, JALE, & HASHEM DABAGHIAN, FATANEH. (2020). Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial. AVICENNA JOURNAL OF PHYTOMEDICINE (AJP), 10(5), 523-532. SID. https://sid.ir/paper/765088/en

    Vancouver: Copy

    YOUSEFI FATEMEH, KASHANIAN MARYAM, Nazem Ismail, BIOOS SOODABEH, SADEGHPOUR OMID, ALIASL JALE, HASHEM DABAGHIAN FATANEH. Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial. AVICENNA JOURNAL OF PHYTOMEDICINE (AJP)[Internet]. 2020;10(5):523-532. Available from: https://sid.ir/paper/765088/en

    IEEE: Copy

    FATEMEH YOUSEFI, MARYAM KASHANIAN, Ismail Nazem, SOODABEH BIOOS, OMID SADEGHPOUR, JALE ALIASL, and FATANEH HASHEM DABAGHIAN, “Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial,” AVICENNA JOURNAL OF PHYTOMEDICINE (AJP), vol. 10, no. 5, pp. 523–532, 2020, [Online]. Available: https://sid.ir/paper/765088/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top